Insulet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Insulet 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PODD

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. 

CEO
Ashley A. McEvoy
CEOAshley A. McEvoy
Employees
5,400
Employees5,400
Headquarters
Acton, Massachusetts
HeadquartersActon, Massachusetts
Founded
2000
Founded2000
Employees
5,400
Employees5,400

PODD Key Statistics

Market cap
14.66B
Market cap14.66B
Price-Earnings ratio
62.69
Price-Earnings ratio62.69
Dividend yield
Dividend yield
Average volume
898.49K
Average volume898.49K
High today
$218.05
High today$218.05
Low today
$207.20
Low today$207.20
Open price
$216.83
Open price$216.83
Volume
893.08K
Volume893.08K
52 Week high
$354.88
52 Week high$354.88
52 Week low
$207.20
52 Week low$207.20

Stock Snapshot

Insulet(PODD) stock is priced at $207.27, giving the company a market capitalization of 14.66B. It carries a P/E multiple of 62.69.

As of 2026-03-27, Insulet(PODD) stock has fluctuated between $207.20 and $218.05. The current price stands at $207.27, placing the stock +0.0% above today's low and -4.9% off the high.

Insulet(PODD) shares are trading with a volume of 893.08K, against a daily average of 898.49K.

In the last year, Insulet(PODD) shares hit a 52-week high of $354.88 and a 52-week low of $207.20.

In the last year, Insulet(PODD) shares hit a 52-week high of $354.88 and a 52-week low of $207.20.

PODD News

Nasdaq 1d
Danaher Achieves #26 Analyst Rank, Surpassing Insulet

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Danaher Corp (Symbol: DHR) has taken over the #26 s...

Danaher Achieves #26 Analyst Rank, Surpassing Insulet
Simply Wall St 3d
Insulet Trials Closed Loop Pod For Type 2 Diabetes As Shares Lag

Insulet (NasdaqGS:PODD) has released new clinical trial results for its fully closed loop Omnipod insulin delivery system in people with type 2 diabetes. The f...

Insulet Trials Closed Loop Pod For Type 2 Diabetes As Shares Lag

Analyst ratings

93%

of 27 ratings
Buy
92.6%
Hold
3.7%
Sell
3.7%

People also own

Based on the portfolios of people who own PODD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.